Novo Nordisk A/S
NVO | NYSE
$40.00
+$0.86 (+2.20%)
At close: Oct 30, 2026, 4:00 PM ET
$39.88
-$0.12 (-0.30%)
Pre-market:
Nov 2, 2026, 8:05 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 78.49B | 96.82B | 79.14B | 74.98B | 76.86B | 78.09B | 85.68B | 71.31B | 68.06B | 65.35B | 65.86B | 58.73B | 54.3B | 53.37B | 48.09B | 45.57B | 41.27B | 42.03B | 38.33B | 35.62B | 33.04B | 33.8B |
Cost of Revenue | 17.1B | 13.6B | 15.15B | 17.9B | 12.85B | 12.89B | 13.02B | 11.31B | 10.27B | 9.92B | 10.01B | 9.71B | 7.86B | 8.18B | 8.26B | 7.2B | 6.07B | 6.92B | 6.24B | 6.06B | 5.55B | 5.81B |
Gross Profit | 61.39B | 83.23B | 64B | 57.07B | 64.01B | 65.2B | 72.66B | 60B | 57.79B | 55.43B | 55.85B | 49.02B | 46.44B | 45.19B | 39.83B | 38.37B | 35.2B | 35.11B | 32.09B | 29.56B | 27.49B | 27.99B |
Operating Income | 27.06B | 59.62B | 31.74B | 23.68B | 33.45B | 38.79B | 36.74B | 33.82B | 25.93B | 31.85B | 26.77B | 26.91B | 23.89B | 25.01B | 17.09B | 20.18B | 18.39B | 19.15B | 13.63B | 15.25B | 14.78B | 14.98B |
Interest Income | 1.31B | 6.05B | 2.45B | 1.84B | 5.31B | 3.43B | 3.91B | 1.38B | 960M | 2.15B | n/a | 3.32B | 647M | 852M | n/a | 1.57B | 1.66B | 210M | 256.06M | 790M | 138M | 1.75B |
Pretax Income | 26.88B | 62.17B | 34.19B | 25.52B | 33.81B | 37.03B | 35.56B | 34.38B | 25.33B | 31.92B | 27.62B | 28.06B | 24.25B | 24.74B | 16.32B | 18.03B | 16.8B | 17.92B | 13.11B | 15.11B | 14.92B | 15.94B |
Net Income | 20.99B | 48.56B | 26.89B | 20.01B | 26.5B | 29.03B | 28.23B | 27.3B | 20.05B | 25.41B | 21.96B | 22.48B | 19.43B | 19.81B | 13.59B | 14.41B | 13.32B | 14.21B | 10.89B | 12.12B | 12.12B | 12.62B |
Selling & General & Admin | 16.31B | 13.22B | 17.44B | 17.88B | 18.85B | 16.11B | 20.28B | 16.59B | 16.09B | 14.41B | 18.63B | 14.08B | 15.41B | 13.48B | 15.09B | 12.61B | 11.83B | 11.15B | 12.82B | 10.14B | 8.91B | 9.19B |
Research & Development | 17.79B | 10.28B | 14.65B | 15.39B | 11.69B | 10.31B | 13.8B | 9.49B | 16.17B | 8.61B | 10.46B | 8.13B | 7.13B | 6.73B | 8.09B | 5.63B | 5.12B | 5.21B | 5.63B | 4.25B | 3.94B | 3.94B |
Other Expenses | 234M | 106M | 174M | 117M | 23M | -14M | 1.84B | 101M | -405M | 568M | -3M | -98M | 15M | -33M | -433M | -60M | -149M | -392M | 4M | -81M | -134M | -121M |
Operating Expenses | 34.33B | 23.61B | 32.26B | 33.39B | 30.56B | 26.41B | 35.92B | 26.18B | 31.85B | 23.59B | 29.08B | 22.11B | 22.56B | 20.18B | 22.74B | 18.18B | 16.81B | 15.97B | 18.46B | 14.31B | 12.72B | 13.01B |
Interest Expense | 1.5B | 3.5B | n/a | n/a | 4.96B | 5.18B | 5.09B | 821M | 1.56B | 2.07B | 916M | 2.17B | 281M | 1.12B | 730.5M | 3.73B | 3.25B | 1.44B | 781.3M | 927M | n/a | 797M |
Selling & Marketing Expenses | 15B | 12.08B | 15.89B | 16B | 17.53B | 14.89B | 18.7B | 15.21B | 14.93B | 13.26B | 17.17B | 12.82B | 14.34B | 12.41B | 13.74B | 11.45B | 10.84B | 10.18B | 11.63B | 9.12B | 8B | 8.26B |
Cost & Expenses | 51.43B | 37.21B | 47.41B | 51.29B | 43.41B | 39.3B | 48.95B | 37.49B | 42.13B | 33.5B | 39.1B | 31.82B | 30.41B | 28.36B | 31.01B | 25.38B | 22.87B | 22.88B | 24.7B | 20.37B | 18.26B | 18.82B |
Income Tax Expense | 5.89B | 13.62B | 7.29B | 5.51B | 7.3B | 8B | 7.33B | 7.08B | 5.28B | 6.51B | 5.66B | 5.59B | 4.83B | 4.92B | 2.72B | 3.63B | 3.48B | 3.71B | 2.22B | 2.99B | 2.79B | 3.32B |
Shares Outstanding (Basic) | 4.43B | 4.44B | 4.45B | 4.45B | 4.45B | 4.44B | 4.45B | 4.45B | 4.46B | 4.46B | 4.46B | 4.48B | 4.49B | 4.5B | 4.51B | 4.52B | 4.54B | 4.55B | 4.57B | 4.58B | 4.6B | 4.62B |
Shares Outstanding (Diluted) | 4.44B | 4.45B | 4.45B | 4.45B | 4.45B | 4.45B | 4.46B | 4.46B | 4.47B | 4.47B | 4.48B | 4.49B | 4.5B | 4.51B | 4.52B | 4.54B | 4.55B | 4.57B | 4.59B | 4.59B | 4.61B | 4.63B |
EPS (Basic) | 4.74 | 10.93 | 6.06 | 4.50 | 5.96 | 6.54 | 6.34 | 6.13 | 4.50 | 5.70 | 4.92 | 5.02 | 4.33 | 4.40 | 3.02 | 3.17 | 2.93 | 3.11 | 2.38 | 2.65 | 2.63 | 2.74 |
EPS (Diluted) | 4.74 | 10.91 | 6.04 | 4.50 | 5.96 | 6.53 | 6.33 | 6.12 | 4.49 | 5.68 | 4.91 | 5 | 4.32 | 4.39 | 3.01 | 3.18 | 2.93 | 3.11 | 2.38 | 2.64 | 2.63 | 2.73 |
EBITDA | 38.68B | 69.21B | 39.75B | 33.27B | 43.6B | 46.05B | 45.85B | 37.36B | 35.74B | 36.91B | 28.51B | 32.76B | 26.71B | 27.58B | 9.51B | 23.8B | 21.68B | 21.01B | 13.81B | 17.39B | 16.13B | 18.11B |
EBIT | 28.38B | 65.67B | 34.19B | 25.52B | 38.76B | 42.22B | 40.65B | 35.21B | 26.89B | 33.99B | 25.52B | 30.23B | 24.54B | 25.86B | 8.28B | 21.76B | 20.05B | 19.36B | 11.73B | 16.04B | 14.92B | 16.74B |
Depreciation & Amortization | 10.3B | 3.54B | 5.56B | 7.76B | 4.83B | 3.83B | 5.2B | 2.15B | 8.85B | 2.91B | 2.99B | 2.53B | 2.18B | 1.72B | 1.23B | 2.04B | 1.64B | 1.65B | 2.08B | 1.35B | 1.22B | 1.38B |
Add to Watchlist
Select watchlists to add or remove NVO